glp-1 in pregnancy GLP-1-Mediated and Neonatal Complications Mice JCI Insight - Maternal antagonism
Description
About 1 in 8 adults are now taking a GLP-1 drug for obesity, disease, or both, up 6 percentage points from May 2024, according to KFF poll results released in November
Menopause-related estrogen decline accelerates bone loss and increases fracture risk
R., Thomas S
CONCLUSIN La DM2 es una enfermedad progresiva que habitualmente requiere de 2 o ms frmacos para lograr un adecuado control
The minimum oxygen saturation significantly increased from 80.3 5.8% to 83.4 5.8% in the liraglutide treated group compared to unsignificant changes in the placebo-controlled group only treated with CPAP
doi: 10.1016/j.phrs.2019.104448
